X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare FDC LTD. with Cipla - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FDC LTD. vs CIPLA - Comparison Results

CIPLA 
   Change

Cipla is one of the largest pharma companies in the domestic market and has presence in formulations and bulk drugs manufacturing. All the bulk drug manufacturing facilities of the company have been approved by various authorities including the US FD... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FDC LTD. CIPLA FDC LTD./
CIPLA
 
P/E (TTM) x 22.2 40.6 54.7% View Chart
P/BV x 5.0 3.7 133.8% View Chart
Dividend Yield % 0.9 0.5 208.7%  

Financials

 FDC LTD.   CIPLA
EQUITY SHARE DATA
    FDC LTD.
Mar-14
CIPLA
Mar-18
FDC LTD./
CIPLA
5-Yr Chart
Click to enlarge
High Rs144663 21.6%   
Low Rs79479 16.5%   
Sales per share (Unadj.) Rs47.6189.0 25.2%  
Earnings per share (Unadj.) Rs7.617.6 43.2%  
Cash flow per share (Unadj.) Rs9.034.0 26.5%  
Dividends per share (Unadj.) Rs2.253.00 75.0%  
Dividend yield (eoy) %2.00.5 384.9%  
Book value per share (Unadj.) Rs47.5176.7 26.9%  
Shares outstanding (eoy) m177.83805.12 22.1%   
Bonus/Rights/Conversions BBESOP-  
Price / Sales ratio x2.33.0 77.4%   
Avg P/E ratio x14.632.5 45.1%  
P/CF ratio (eoy) x12.316.8 73.6%  
Price / Book Value ratio x2.33.2 72.4%  
Dividend payout %29.617.1 173.4%   
Avg Mkt Cap Rs m19,784459,724 4.3%   
No. of employees `000NA23.6 0.0%   
Total wages/salary Rs m1,22126,901 4.5%   
Avg. sales/employee Rs ThNM6,446.1-  
Avg. wages/employee Rs ThNM1,139.4-  
Avg. net profit/employee Rs ThNM600.0-  
INCOME DATA
Net Sales Rs m8,459152,193 5.6%  
Other income Rs m3943,577 11.0%   
Total revenues Rs m8,852155,769 5.7%   
Gross profit Rs m2,07028,264 7.3%  
Depreciation Rs m24913,228 1.9%   
Interest Rs m311,142 2.7%   
Profit before tax Rs m2,18417,470 12.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m-225-28 809.0%   
Extraordinary Inc (Exp) Rs m0-775 0.0%   
Tax Rs m6062,501 24.2%   
Profit after tax Rs m1,35314,166 9.6%  
Gross profit margin %24.518.6 131.8%  
Effective tax rate %27.714.3 193.7%   
Net profit margin %16.09.3 171.9%  
BALANCE SHEET DATA
Current assets Rs m4,355108,141 4.0%   
Current liabilities Rs m1,79238,322 4.7%   
Net working cap to sales %30.345.9 66.1%  
Current ratio x2.42.8 86.1%  
Inventory Days Days4497 45.8%  
Debtors Days Days2574 33.2%  
Net fixed assets Rs m3,025109,411 2.8%   
Share capital Rs m1791,610 11.1%   
"Free" reserves Rs m8,243140,682 5.9%   
Net worth Rs m8,453142,292 5.9%   
Long term debt Rs m1136,621 0.0%   
Total assets Rs m10,557228,606 4.6%  
Interest coverage x71.416.3 438.3%   
Debt to equity ratio x00.3 0.5%  
Sales to assets ratio x0.80.7 120.4%   
Return on assets %13.16.7 195.8%  
Return on equity %16.010.0 160.8%  
Return on capital %23.510.0 236.2%  
Exports to sales %13.332.8 40.6%   
Imports to sales %3.30-   
Exports (fob) Rs m1,12649,883 2.3%   
Imports (cif) Rs m283NA-   
Fx inflow Rs m1,14651,691 2.2%   
Fx outflow Rs m35521,033 1.7%   
Net fx Rs m79130,658 2.6%   
CASH FLOW
From Operations Rs m1,48514,628 10.2%  
From Investments Rs m-620-8,540 7.3%  
From Financial Activity Rs m-753-3,855 19.5%  
Net Cashflow Rs m1132,431 4.6%  

Share Holding

Indian Promoters % 68.9 16.0 430.6%  
Foreign collaborators % 0.0 20.8 -  
Indian inst/Mut Fund % 4.7 12.2 38.5%  
FIIs % 7.5 23.7 31.6%  
ADR/GDR % 0.0 1.1 -  
Free float % 19.0 26.2 72.5%  
Shareholders   23,730 161,166 14.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FDC LTD. With:   ABBOTT INDIA  JUBILANT LIFE SCIENCES  BIOCON LTD  PIRAMAL ENTERPRISES  NATCO PHARMA  

Compare FDC LTD. With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Slumps Over 275 Points; Realty and Banking Stocks Witness Selling(Closing)

After trading on a volatile note throughout the day, share markets in India witnessed selling pressure during the closing hours and ended the day in red.

Related Views on News

CIPLA Announces Quarterly Results (1QFY19); Net Profit Up 4.7% (Quarterly Result Update)

Aug 10, 2018 | Updated on Aug 10, 2018

For the quarter ended June 2018, CIPLA has posted a net profit of Rs 4 bn (up 4.7% YoY). Sales on the other hand came in at Rs 39 bn (up 11.7% YoY). Read on for a complete analysis of CIPLA's quarterly results.

FDC LTD. Announces Quarterly Results (1QFY19); Net Profit Up 74.5% (Quarterly Result Update)

Aug 6, 2018 | Updated on Aug 6, 2018

For the quarter ended June 2018, FDC LTD. has posted a net profit of Rs 511 m (up 74.5% YoY). Sales on the other hand came in at Rs 3 bn (up 16.7% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Cipla: Extraordinary Income Boosts Net Profits (Quarterly Results Update - Detailed)

Oct 30, 2017

Proceeds from the sale of the South African animal business bolstered Cipla's net profits for the quarter.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

Is It the Right Time to Buy Pharma Stocks Now?(The 5 Minute Wrapup)

Sep 12, 2018

Is the pharma sector poised for a comeback? Is the worst over? I believe so.

Want Bigger Returns Than You Thought Possible? This is Where You Should Look(Profit Hunter)

Sep 12, 2018

Richa has discovered the single most profitable opportunity in the market - read on to discover more...

Investors Are Redeeming From Equity Mutual Funds Now. Should You?(Outside View)

Sep 12, 2018

PersonalFN elucidates if you should redeem from equity mutual fund now, and the approach to follow before you decide to sell mutual funds.

Are You Blindly Investing In Equities? Read This...(Outside View)

Sep 11, 2018

PersonalFN explains how blindly investing in equities can prove hazardous to your wealth and health.

Outperformance of Strong Established Brands in the Indian Stock market(Chart Of The Day)

Sep 14, 2018

Strong Well established Indian Brands have comfortably outperformed the index in the decade post the global financial crisis.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FDC LTD. SHARE PRICE


Sep 21, 2018 (Close)

TRACK FDC LTD.

  • Track your investment in FDC LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FDC LTD. 8-QTR ANALYSIS

COMPARE FDC LTD. WITH

MARKET STATS